CCCC
Price
$1.52
Change
+$0.01 (+0.66%)
Updated
Jul 2 closing price
Capitalization
107.22M
34 days until earnings call
GBIO
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Jul 2 closing price
Capitalization
22.65M
34 days until earnings call
Interact to see
Advertisement

CCCC vs GBIO

Header iconCCCC vs GBIO Comparison
Open Charts CCCC vs GBIOBanner chart's image
C4 Therapeutics
Price$1.52
Change+$0.01 (+0.66%)
Volume$1.77M
Capitalization107.22M
Generation Bio
Price$0.34
Change+$0.02 (+6.25%)
Volume$696.32K
Capitalization22.65M
CCCC vs GBIO Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. GBIO commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a StrongBuy and GBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (CCCC: $1.52 vs. GBIO: $0.34)
Brand notoriety: CCCC and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 158% vs. GBIO: 92%
Market capitalization -- CCCC: $107.22M vs. GBIO: $22.65M
CCCC [@Biotechnology] is valued at $107.22M. GBIO’s [@Biotechnology] market capitalization is $22.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while GBIO’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 5 bearish.
  • GBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CCCC and GBIO are a bad buy in the short-term.

Price Growth

CCCC (@Biotechnology) experienced а -1.30% price change this week, while GBIO (@Biotechnology) price change was -7.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

GBIO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($107M) has a higher market cap than GBIO($22.7M). CCCC YTD gains are higher at: -57.778 vs. GBIO (-68.123). GBIO has higher annual earnings (EBITDA): -69.2M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. GBIO (158M). CCCC has less debt than GBIO: CCCC (64.4M) vs GBIO (87.6M). CCCC has higher revenues than GBIO: CCCC (39.8M) vs GBIO (24.6M).
CCCCGBIOCCCC / GBIO
Capitalization107M22.7M471%
EBITDA-102.74M-69.2M148%
Gain YTD-57.778-68.12385%
P/E RatioN/AN/A-
Revenue39.8M24.6M162%
Total Cash215M158M136%
Total Debt64.4M87.6M74%
TECHNICAL ANALYSIS
Technical Analysis
CCCCGBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSXLF0.310.02
+5.34%
GREAT PACIFIC GOLD CORP.
EKTAY5.170.17
+3.40%
Elekta AB
CPPMF0.13N/A
+2.73%
Coppernico Metals Inc
MTNOY8.00-0.10
-1.23%
MTN Group Ltd.
CYDY0.27-0.01
-2.22%
CytoDyn Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+0.66%
KYMR - CCCC
56%
Loosely correlated
+0.20%
CRBU - CCCC
55%
Loosely correlated
+9.20%
FATE - CCCC
53%
Loosely correlated
-2.19%
BEAM - CCCC
53%
Loosely correlated
+13.46%
RXRX - CCCC
51%
Loosely correlated
+1.56%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+5.59%
CCCC - GBIO
50%
Loosely correlated
+0.66%
IDYA - GBIO
49%
Loosely correlated
+3.79%
ATXS - GBIO
48%
Loosely correlated
+5.52%
FHTX - GBIO
48%
Loosely correlated
+2.26%
ATNM - GBIO
48%
Loosely correlated
+5.93%
More